Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.

NCT07763847 is registered in ClinicalTrials.gov with Mst.Sumyara Khatun as lead sponsor.

NCT NCT07763847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07763847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.
Lead sponsor
Mst.Sumyara Khatun
Phase
Not applicable
Overall status
Completed
Start date
April 17, 2025
Completion date
April 16, 2026
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioma